SCOTT HAGEN: Open Payments
NPI 1679752315 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$178 in 9 payments from 6 companies in 2025. Trend: 2023 $473 · 2024 $428 · 2025 $178
Food & beverage: $178
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $68 |
| Lilly USA, LLC | 2 | $44 |
| Novo Nordisk Inc | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Ardelyx, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $7 |
Products named: LINZESS, QULIPTA, Ozempic, MOUNJARO, ZEPBOUND, ZENPEP, IBSRELA, VOQUEZNA.
Industry payments across CA — which companies pay providers there.
